MedAdvisor partners Apotex
September 17, 2015
Australian adherence software
systems company MedAdvisor has
partnered with Australia’s largest
generic pharmaceutical company
Apotex to enhance its exposure to
the community pharmacy sector.
The marketing and distribution
agreement will give MedAdvisor,
which is in the process of raising
capital in an Initial Public Offering
(PD 02 Sep), access to Apotex’s
wide reaching pharmacy channels
throughout the country.
Apotex Asia-Pacific md Roger
Millichamp said the partnership
leverages the capabilities and
strengths of each organisation “to
deliver a relevant and important
program to community pharmacy.”
MedAdvisor ceo Robert Read
highlighted that the company
has more than 88,000 users and
more than 1,250 pharmacies
already on the platform and that
the relationship with Apotex will
increase the company’s community
pharmacy reach even further.
“Users of the MedAdvisor
platform are 97% loyal to their
favourite pharmacy and adherence
is lifted by ~20%,” he said.
“In the face of PBS reform,
improving loyalty and adherence is
critical for pharmacy.”
MEAN WHILE MedAdvisor also
announced it has entered a new
services agreement with Guildlink
which will see the GuildCare
console continuing to host the
MedAdvisor platform.
Guildlink will also continue to
provide MedAdvisor with support
and maintenance services.
MedAdvisor has been the most
downloaded medical app in
Australian Apple and Android stores
since 2013, the company said.
Earlier this month MedAdvisor
invited pharmacist subscribers to
the service to consider investing in
the float via a Priority Investment
Offer, with participants qualifying
for a three-month subscription free
period for one pharmacy for every
$3,000 worth of shares.
As well as the Apotex and
Guildlink pacts the company
has also established a sales and
marketing partnership with Bupa.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Sep 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Sep 15
